Publication: 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis
| dc.contributor.authors | Turhal, Nazim S.; Dane, Faysal; Dede, Fuat; Gumus, Mahmut; Yumuk, P. Fulden; Cakalagaoglu, Fulya; Savci, Dilara; Karaman, Munire; Gulluoglu, Bahadir; Turoglu, H. Turgut | |
| dc.date.accessioned | 2022-03-25T19:39:29Z | |
| dc.date.accessioned | 2026-01-10T17:00:40Z | |
| dc.date.available | 2022-03-25T19:39:29Z | |
| dc.date.issued | 2004 | |
| dc.description.abstract | BACKGROUND: Vascular endothelial growth factor (VEGF) is a prognostic factor in breast cancer. One of the mechanisms of extra-skeletal uptake of Tc-99m-methylenediphosphonate (MDP) is suggested to be tumor vascularity. We studied the correlation between MDP uptake and VEGF and compared the diagnostic accuracy of mammography versus MDP-scintimammography (MDP-S). MATERIALS AND METHODS: Fifty-four patients with suspicion of breast cancer were evaluated. Breast images were collected 5-10 minutes after injection of Tc-99m-MDP prior to biopsy. Tissue slides were stained using a rabbit-polyclonal anti-VEGF. RESULTS: MDP-S showed a diagnostic accuracy of 83.3% in BIRADS category 4 lesions. Four out of 23 benign lesions were false-positive. The tumor to background (TM/BG) ratio of early images of MDP-S was correlated with VEGF staining (p: 0.014) and with tumor size (p: 0.006). CONCLUSION: Early images of Tc-99m-MDP-S may satisfactorily identify cancers with increased neovascularization. MDP-S seems to be an accurate imaging modality, especially in BIRADS category 4 lesions. | |
| dc.identifier.issn | 0250-7005 | |
| dc.identifier.pubmed | PMID: 15274391 | |
| dc.identifier.uri | https://hdl.handle.net/11424/254851 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Anticancer Research | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Adult | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Middle Aged | |
| dc.subject | Aged | |
| dc.subject | Aged, 80 and over | |
| dc.subject | Vascular Endothelial Growth Factor A | |
| dc.subject | Radionuclide Imaging | |
| dc.subject | Radiopharmaceuticals | |
| dc.subject | Breast Neoplasms | |
| dc.subject | Neovascularization, Pathologic | |
| dc.subject | Mammography | |
| dc.subject | Technetium Tc 99m Medronate | |
| dc.title | 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 2006 | |
| oaire.citation.startPage | 1999 | |
| oaire.citation.title | Anticancer Research | |
| oaire.citation.volume | 3b |
Files
Original bundle
1 - 1 of 1
